Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2010New England Journal of MedicineOpen Access

Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

View Full Paper
Ask AI
Bookmark
Share

Population

107 subjects: 38 with pathogenic sarcomere mutations and overt hypertrophic cardiomyopathy, 39 with…

Design

Cross-sectional

Authors

Carolyn Y. Ho
Carolyn Y. HoHeart Failure / Cardiomyopathy
BLBegoña LópezHeart Failure & TransplantOCOtávio R. Coelho‐FilhoCardiac Imaging

Discussion

Loading...

Member takes

Implication

May flag preclinical disease in sarcomere carriers; leaves open prospective validation before clinical use.

Key Points

  • To determine whether profibrotic alterations in collagen metabolism and myocardial fibrosis occur in sarcomere-mutation carriers before the development of left ventricular hypertrophy.
  • Evaluated 38 subjects with pathogenic sarcomere mutations and overt hypertrophic cardiomyopathy, 39 mutation carriers without left ventricular hypertrophy, and 30 mutation-negative controls.
  • Assessed cardiac structure and fibrosis using echocardiography, cardiac MRI with late gadolinium enhancement, and serum biomarkers of collagen turnover (PICP and CITP).
  • Serum PICP levels were 31% higher in mutation carriers without left ventricular hypertrophy and 69% higher in overt hypertrophic cardiomyopathy compared with controls (P<0.001).
  • The ratio of PICP to C-terminal telopeptide of type I collagen was significantly increased only in subjects with overt hypertrophic cardiomyopathy.
  • Late gadolinium enhancement on cardiac MRI was present in 71% of subjects with overt hypertrophic cardiomyopathy but was absent (0%) in mutation carriers without left ventricular hypertrophy.

Structured PICO

P
Population
107 subjects: 38 with pathogenic sarcomere mutations and overt hypertrophic cardiomyopathy, 39 with mutations but no left ventricular hypertrophy, and 30 controls without mutations.
C
Comparator
Controls without mutations
O
Outcome
Levels of serum C-terminal propeptide of type I procollagen (PICP) and presence of late gadolinium enhancement on cardiac MRIsurrogate

Increased myocardial collagen synthesis, indicated by elevated serum PICP, precedes the development of left ventricular hypertrophy or visible MRI fibrosis in sarcomere-mutation carriers.

Cite This Study

Ho et al. (2010) studied this question.

synapsesocial.com/papers/6a032c73a7089d64356539b0https://doi.org/10.1056/nejmoa1002659

Topics

EchocardiographyHypertrophic cardiomyopathy
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I2005 · 99 citations
  2. 2Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy2008 · 293 citations
  3. 3Long-Term Changes in Collagen Formation Expressed by Serum Carboxyterminal Propeptide of Type-I Procollagen and Relation to Left Ventricular Function after Acute Myocardial Infarction2001 · 26 citations
  4. 4Polony Multiplex Analysis of Gene Expression (PMAGE) in Mouse Hypertrophic Cardiomyopathy2007 · 204 citations
  5. 5Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation2001 · 480 citations